Success Metrics

Clinical Success Rate
80.0%

Based on 12 completed trials

Completion Rate
80%(12/15)
Active Trials
1(4%)
Results Posted
17%(2 trials)
Terminated
3(11%)

Phase Distribution

Ph phase_2
4
14%
Ph phase_4
2
7%
Ph not_applicable
7
25%
Ph phase_1
13
46%
Ph early_phase_1
2
7%

Phase Distribution

15

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
2(7.1%)
Phase 1Safety & dosage
13(46.4%)
Phase 2Efficacy & side effects
4(14.3%)
Phase 4Post-market surveillance
2(7.1%)
N/ANon-phased studies
7(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.6%

12 of 17 finished

Non-Completion Rate

29.4%

5 ended early

Currently Active

1

trials recruiting

Total Trials

28

all time

Status Distribution
Active(6)
Completed(12)
Terminated(5)
Other(5)

Detailed Status

Completed12
unknown5
Not yet recruiting4
Terminated3
Withdrawn2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.1%)
Phase 113 (46.4%)
Phase 24 (14.3%)
Phase 42 (7.1%)
N/A7 (25.0%)

Trials by Status

enrolling_by_invitation14%
recruiting14%
not_yet_recruiting414%
unknown518%
withdrawn27%
terminated311%
completed1243%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT02636517Phase 1

Fecal Microbiome Transplant

Enrolling By Invitation
NCT04090346Phase 4

Fecal Microbiota Transplant

Completed
NCT05998213Phase 2

Transfer of Feces in Ulcerative Colitis 2

Completed
NCT04630847Phase 1

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Not Yet Recruiting
NCT05967871Phase 1

Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth

Recruiting
NCT06647277Phase 1

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Not Yet Recruiting
NCT06593366Not Applicable

Fecal Microbiota Transplant for Anorexia Nervosa

Not Yet Recruiting
NCT04139577Phase 1

FMT In High-Risk Acute GVHD After ALLO HCT

Completed
NCT06227845Not Applicable

Preterm Infant Intestinal Microbiota Development and Maternal Fecal Transplant

Not Yet Recruiting
NCT05981430Not Applicable

Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae

Unknown
NCT04116775Phase 2

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Unknown
NCT03367910Phase 1

Fecal Microbiota Transplantation (FMT) for MDRO UTI

Completed
NCT05229289Not Applicable

Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy

Unknown
NCT02394275Phase 2

A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

Terminated
NCT02255617Phase 1

Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study

Completed
NCT03029078Phase 4

FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?

Completed
NCT03998423Phase 1

Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease

Terminated
NCT03363022Not Applicable

To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure

Withdrawn
NCT02254811Phase 2

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Completed
NCT04056026Early Phase 1

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
28